Investors / Hungary / Vespucci Partners
Vespucci Partners
Venture capital · Budapest, Hungary · Europe
Vespucci Partners is a venture capital fund manager based in Budapest, Hungary. It manages closed-end venture capital funds and invests in Central European startup teams, providing capital along with portfolio management guidance and contacts for international expansion.
In its own wordsgreen technologyautomotivehealthagro-foodfintechindustry 4.0
Your fit with Vespucci Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsVespucci Partners lists 9 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (13%), Consumer (13%) and Industrial & Manufacturing (13%). 57% of its companies are based in Hungary. It invests most often alongside Gamma Capital Partners, Naples Technology Ventures and Purim Ventures.
No funding round on record names Vespucci Partners yet, so the figures come from its portfolio page.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 13% | 15% |
| Consumer | 13% | 3% |
| Industrial & Manufacturing | 13% | 7% |
| Enterprise Software | 13% | 8% |
| Developer Tools | 13% | 0% |
| Real Estate & Construction | 7% | 3% |
| Fintech | 7% | 12% |
| E-commerce & Marketplaces | 7% | 6% |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers9100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 19th | 9 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 1th | 13% in its largest sector |
| Reach | 70th | 4 countries |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Gamma Capital Partners
Compare Vespucci Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
as stated on its sitePortfolio
9 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Beam Live unifies communications, operational CRM, and resource planning into one real-time operational fabric | AI & Machine LearningEnterprise Software | Portfolio page | ||
| The company provides point of sale terminals, online invoicing, and other payment solutions. | FintechE-commerce & Marketplaces | Portfolio page | ||
| Haris Digital provides machine digitization solutions to help manufacturers upgrade their production processes | Industrial & Manufacturing | Portfolio page | ||
| Swapp rents out cars in Dubai and other locations in the UAE | Real Estate & ConstructionConsumer | Portfolio page | ||
| PolyXLabs helps consumer goods companies phase out toxic, non-recyclable plastics by providing a biodegradable plastic replacement created using spent coffee grounds. | ConsumerSpace & Defense | Portfolio page | ||
| RocketShepherd provided an automated startup database to help find and connect with innovative startups | Developer ToolsDeveloper Tools | Portfolio page | ||
| Transcend develops design automation software for critical infrastructure | Industrial & ManufacturingEnterprise Software | Portfolio page | ||
| Triton Labs provides medical services and operates private hospitals and medical centers. | Healthcare & Biotech | Portfolio page | ||
| XPAMAC Inc is a biotechnology startup offering cell line development services for the biotech industry, developing next-generation mammalian cell lines for the efficient production of therapeutic proteins | Healthcare & Biotech | Portfolio page |
About this data
site last read 8 Nov 2026- Site
- vespuccipartners.com
- Last read
- 8 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 9
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Vespucci Partners' profile as data
Pull Vespucci Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/vespuccipartners.com
# also
GET /v1/firms/vespuccipartners.com/portfolio
GET /v1/firms/vespuccipartners.com/coinvestors
GET /v1/firms/vespuccipartners.com/news